Overview

Gabapentin as an Adjunct to Paracervical Block for Perioperative Pain Management

Status:
Completed
Trial end date:
2018-06-26
Target enrollment:
0
Participant gender:
Female
Summary
This is a randomized controlled trial of gabapentin 600 mg compared to placebo given 1-2 hours preoperatively in conjunction with perioperative paracervical block for surgical abortion. The researchers hypothesize that adding gabapentin to local anesthesia will reduce perioperative and postoperative pain associated with surgical abortion. Additionally, the researchers hypothesize that gabapentin will reduce nausea, vomiting, anxiety, and consumption of pain medication.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Emory University
Collaborator:
Society of Family Planning
Treatments:
Gabapentin
gamma-Aminobutyric Acid
Criteria
Inclusion Criteria:

- Women >=18 years-old

- Presenting for a surgical abortion

- Fluency in English and able to provide informed consent

- Has a driver to take them home following the procedure

Exclusion Criteria:

- Allergy, sensitivity or contraindication to gabapentin

- Severe renal disease

- Currently using gabapentin or pregabalin

- Contraindication to outpatient abortion under local anesthesia